Lack of correlation between repair of DNA interstrand cross-links and differential sensitivity of G0 and proliferating CD4+ lymphocytes towards cisplatin

Neoplasma

Volumn 46, Issue 6, 1999, Pages 342-348

  Bartosova Z ^a   Horak, I D ^b   Pirsel M ^a   Bohr, V A ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b NONE

Author keywords

Cisplatin; Gene specific DNA repair; Interstrand cross link

Indexed keywords

CISPLATIN; DIHYDROFOLATE REDUCTASE;

APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; ONCOGENE C MYC; T LYMPHOCYTE;

EID: 0343851649     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. + lymphocytes reflects transcription and proliferation. Mutat. Res., 363, 1996, 191-199.
2. BOERRIGTER, M.E., VIJG, J.: Induction and disappearance of DNA single-strand breaks in human B and T lymphocytes after exposure to ethylnitrosourea. Mutat. Res., 255, 1991, 49-55.
3. BYEFIELD, J.E., CALABRO-JONES, P.M.: Carrier-dependent and carrier-independent transport of anti-cancer alkylating drugs. Nature, 294, 1981, 281-283.
4. CHEN, G., ZELLER, W.J.: In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line. J. Cancer Res. Clin. Oncol., 116, 1990, 443-447.
5. DAMIA, G., GUILDI, G., D'INCALCI, M.: Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur. J. Cancer, 34, 1998, 1783-1788.
6. DRÖGE, W., ECK, H.-P., GMÜNDER, H., MIHM, S.: Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives. Am. J. Med., 91, 1991, 140-144.
7. DRÖGE, W., SCHULZE-OSTHOFF, K., MIHM, S., GALTER, D., SCHENK, H., ECK, H.-P., ROTH, S., GMÜNDER, H.: Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J., 8, 1994, 1131-1138.
8. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci., 93, 1996, 6443-6447.
9. DUCORE, J.M., ERICKSON, L.C., ZWELLING, L.A., LAURENT, G., KOHN, K.W.: Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum (II) and L-phenylalanine mustard. Cancer Res., 42, 1982, 897.
10. EVANS, D.L., TILBY, M., DIVE, C.: Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res., 54, 1994, 1596-1603.
11. FICHTINGER-SCHEPMAN, A.M.J., VAN OOSTEROM, A.T., LOHMAN, P.H.M., BERENDS, F.: Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay? Mutat. Res., 190, 1987, 59-62.
12. FREEMAN, S.E., RYAN, S.L.: Excision repair of pyrimidine dimers in human peripheral blood lymphocytes: Comparison between mitogen stimulated and unstimulated cells. Mutat. Res., 194, 1988, 143-150.
13. FUTSCHER, B.W., PIEPER, R.O., DALTON, W.S., ERICKSON, L.C.: Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR. Cell Growth Differ., 3, 1992, 217-223.
14. HANSSON, J., FICHTINGER-SHEPMAN, A.M., EDGREN, M., RINGBORG, U.: Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin. Eur. J. Cancer, 27, 1991, 1039-1045.
15. HANSSON, J., LEWENSOHN, R., RINGBORG, U.: Cis-diamminedichloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis. Acta Oncol., 27, 1988, 383-392.
16. 2 cell cycle checkpoint.Cancer Res., 55, 1995, 3721-3725.
17. ISLAS, A.L., VOS, J-M.H., HANAWALT, P.C.: Differential introduction and repair of psoralen photoadducts to DNA in specific human genes. Cancer Res., 51, 1991, 2867-2873.
18. JIRICNY, J.: Eukaryotic mismatch repair. Mutat. Res., 409, 1998, 107-121.
19. JONES, J.C., ZHEN, W., REED, E., PARKER, R.J., SANCAR, A., BOHR, V.A.: Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J. Biol. Chem., 266, 1991, 7101-7107.
20. KAMINSKAS, E., LI, J.C.: Repair of DNA damage induced by oxygen radicals in human non-proliferating and proliferating lymphocytes. Mutat. Res., 274, 1992, 103-110.
21. KAPLAN, J.G., BROWN, D.L., CHALY, N., GREER, W.L., PRASAD, K.V., SEVERINY, A., SAHAI, B.M.: Structural and evolutionary implications of the packaging of DNA for differentiation and proliferation in the lymphocyte. J. Mol. Evol., 26, 1987, 173-179.
22. KAT, A., THILLY, W.G., FANG, W., LONGLEY, M.J., LI, G., MODRICH, P.: An alkylation-toleration, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA, 90, 1995, 6424-6428.
23. KOPP, W.C., WERSTO, R.P.: Flow cytometry in the monitoring of therapeutic trials. In: Manual of Clinical Laboratory and Immunology. Eds: Rose, N.R., Sahey, J.L., Friedman, H. Washington, American Society of Microbiology 1993.
24. .-Thalassemia intermedia. Blood, 79, 1992, 2455-2459.
25. LANZI, C., PEREGO, P., SUPINO, R., ROMANELLI, S., PENSA, T., CARENINI, N., VIANO, I., COLANGELO, D., LEONE, R., APOSTOLI, P., CASSINELLI, G., GAMBETTA, R.A., ZUNINO, F.: Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with low level of cisplatin resistance. Biochem. Pharmacol., 55, 1998, 1247-1254.
26. LARMINAT, F., ZHEN, W., BOHR, VA.: Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential. J. Biol. Chem., 268, 1993, 2649-2654.
27. LARMINAT, F., CAMBOIS, G., ZDZIENICKA, M.Z., DEFAIS, M.: Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin. FEBS Lett., 437, 1998, 97-100.
28. LAVIN, M.F., KIDSON, C.: Repair of ionizing radiation induced DNA damage in human lymphocytes. Nucleic Acids Res., 4, 1997, 4015-4022.
29. LEACH, F.S, POLYAK, K., BURREL, M., JOHNSON, K.A., HILL, D., DUNLOP, M.G., WYLLIE, A.H., PELTOMAKI, P., DE LA CHAPELLE, A., HAMILTON, S.R., KINZLER, K.W., VOGELSTEIN, B.: Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res., 56, 1996, 235-240.
30. MARRA, G., CHANG, C.H.L., LAGHI, L.A., CHAUHAN, D.P., YOUNG, D., BOLAND, C.R.: Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene, 13, 1996, 2189-2196.
31. MASUMOTO, N., NAKANO, S., FUJISHIMA, H., KOHNO, K., NIHO, Y.: v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gall-blader adenocarcinoma cells. Int. J. Cancer., 80, 1999, 731-737.
32. MAY, A., NAIRN, R.S., OKUMOTO, D.S., WASSERMANN, K., STEVNSNER, T., JONES, J.C., BOHR, VA.: Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin. J. Biol. Chem., 268, 1993, 1650-1657.
33. MELLO, J.A., LIPPARD, S.J., ESSIGMANN, J.M.: DNA adducts of cis-diamminedichloroplatinum (II) and its trans isomer inhibit RNA polymerase II differentially in vivo. Biochemistry, 34, 1995, 14 783-14 791.
34. MELLO, J.A., ACHARYA, S., FISHEL, R., ESSIGMANN, J.M.: The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol., 3, 1996, 579-589.
35. MILLER, S.A., DYKES, D.D., POLESKY, H.F.: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1988, 1215-
36. 2 - terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res., 57, 1997, 3253-3257.
37. PEREZ, R.P.: Cellular and molecular determinants of cisplatin resistance. Eur. J. Cancer, 34, 1998, 1535-1542.
38. REED, E.: Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat. Rev., 24, 1998, 331-344.
39. SARIBAN, E., KOHN, K.W., ZLOTOGORSKI, C., LAURENT, G., D'INCALCI, M., DAY III, R.S., SMITH, B.H., KORNBLITH, P.L., ERICKSON, L.C.: DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone. Cancer Res., 15, 1987, 3988-3994.
40. SCHRADER, T.J.: Differences in nucleotide and base DNA excision repair observed during mitogenic stimulation of bovine lymphocytes. Mutat. Res., 273, 1992, 29-42.
41. SCUDIERO, D., NORIN, A.A., KARRAN, P., STRAUSS, B.: DNA excision-repair deficiency of human peripheral blood lymphocytes treated with chemical carcinogens. Cancer Res., 36, 1976, 1397-1403.
42. TENDLER, C.L., GREENBERG, S.J., BURTON, J.D., DANIELPOUR, D., KIM, S.J., BLATTNER, W.A., MAANS, A., WALDMANN, T.A.: Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell. Biochem., 46, 1991, 302-311.
43. VAN HOUTEN, B., GAMPER, H., HEARST, J.E., HOLBROOK, S.R., SANCAR, A.: Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position. Proc. Natl. Acad. Sci., 83, 1986, 8077-8083.
44. VIETTI, T.J.: Cellular kinetics and cancer chemotherapy. In: Clinical Pediatric Oncology. Eds: Fernbach, J.D., Vietti, T.J. St. Louis, Mosby Year Book 1991, 173-212.
45. VOS, J-M.H., HANAWALT, P.C.: Processing of psoralen adducts in an active human gene: Repair and replication of DNA containing monoadducts and interstrand cross-links. Cell, 50, 1987, 789-799.
46. WILSON, T.M., EWEL, A., DUGUID, J.R., EBLE J.N., LESCOE, M.K., FISHEL, R.A., KELLEY, M.R.: Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res., 55, 1995, 5146-5150.
47. YANG, J.K., MASTERS, J.N., ATTARDI, G.: Human dihydrofolate reductase gene organization: Extensive conservation of the G+C rich 5′ non-coding sequence and strong intron size divergence from homologous mammalian genes. J. Mol. Biol., 176, 1984, 169-187.
48. ZHEN, W., LINK, C.J., O'CONNOR, P.M., REED, E., PARKER, R., HOWELL, S.B., BOHR, V.A.: Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Biol., 12, 1992, 1-10.
49. ZLATANOVA, J., YANEVA, J., LEUBA, S.H.: Proteins that specifically recognize cisplatin-damaged DNA: A clue to anticancer activity of cisplatin. FASEB J., 12, 1998, 791-799.